MATA NATHAN L. (Chief Scientific Officer) sold 7.3% of their position (1K shares) of BELITE BIO, INC on the open market
Open‑market sale worth $163.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
American depositary share
Shares
−284.00
Price / share
$162.76
Trade value
$46.22K
% of position
American depositary share
Shares
−524.00
Price / share
$163.52
Trade value
$85.68K
% of position
American depositary share
Shares
−124.00
Price / share
$164.40
Trade value
$20.39K
% of position
American depositary share
Shares
−40.00
Price / share
$165.29
Trade value
$6.61K
% of position
American depositary share
Shares
−3.00
Price / share
$166.91
Trade value
$500.72
% of position
American depositary share
Shares
−16.00
Price / share
$167.16
Trade value
$2.67K
% of position
American depositary share
Shares
−9.00
Price / share
$168.35
Trade value
$1.52K
% of position
Net shares
−1K
Net value
-$163.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American depositary share Direct | 4/20/2026 | S · Sale | −284.00 | $162.76 | $46.22K | 2.1% | 13.67K | 13.38K |
| American depositary share Direct | 4/20/2026 | S · Sale | −524.00 | $163.52 | $85.68K | 3.9% | 13.38K | 12.86K |
| American depositary share Direct | 4/20/2026 | S · Sale | −124.00 | $164.40 | $20.39K | 1.0% | 12.86K | 12.73K |
| American depositary share Direct | 4/20/2026 | S · Sale | −40.00 | $165.29 | $6.61K | 0.3% | 12.73K | 12.69K |
| American depositary share Direct | 4/20/2026 | S · Sale | −3.00 | $166.91 | $500.72 | 0.0% | 12.69K | 12.69K |
| American depositary share Direct | 4/20/2026 | S · Sale | −16.00 | $167.16 | $2.67K | 0.1% | 12.69K | 12.68K |
| American depositary share Direct | 4/20/2026 | S · Sale | −9.00 | $168.35 | $1.52K | 0.1% | 12.68K | 12.67K |
| Total | −1K | -$163.59K | ||||||